18 Nov 2025 | 3 Mins Read
Balaxi Pharma September 2025 net sales dip 8.72% to Rs 19.31 crore
Flipitmoney
Balaxi Pharmaceuticals Limited's standalone quarterly revenue in September 2025 was Rs. 19.31 crore, down 8.72% from Rs. 21.16 crore in September 2024. Net profit increased 96.39% to Rs. 3.26 crore in September 2025, while EBITDA rose 80.14% to Rs. 4.99 crore. EPS also rose to Rs. 0.59 in September 2025.